ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/01/22 | 3,710 | 3,725 | 3,680 | 3,725 | +30 | +0.8% | 123,700 |
2018/01/19 | 3,700 | 3,725 | 3,685 | 3,695 | +30 | +0.8% | 144,900 |
2018/01/18 | 3,750 | 3,755 | 3,665 | 3,665 | -55 | -1.5% | 187,100 |
2018/01/17 | 3,750 | 3,755 | 3,710 | 3,720 | -45 | -1.2% | 149,000 |
2018/01/16 | 3,735 | 3,775 | 3,720 | 3,765 | +45 | +1.2% | 165,000 |
2018/01/15 | 3,705 | 3,730 | 3,705 | 3,720 | +15 | +0.4% | 105,900 |
2018/01/12 | 3,755 | 3,760 | 3,700 | 3,705 | -60 | -1.6% | 163,700 |
2018/01/11 | 3,775 | 3,775 | 3,745 | 3,765 | -20 | -0.5% | 146,400 |
2018/01/10 | 3,820 | 3,820 | 3,775 | 3,785 | +5 | +0.1% | 124,600 |
2018/01/09 | 3,815 | 3,815 | 3,775 | 3,780 | -35 | -0.9% | 284,700 |
2018/01/05 | 3,825 | 3,845 | 3,770 | 3,815 | +5 | +0.1% | 225,800 |
2018/01/04 | 3,770 | 3,825 | 3,750 | 3,810 | +65 | +1.7% | 220,700 |
2017/12/29 | 3,755 | 3,765 | 3,735 | 3,745 | +5 | +0.1% | 89,500 |
2017/12/28 | 3,775 | 3,790 | 3,740 | 3,740 | -45 | -1.2% | 136,000 |
2017/12/27 | 3,800 | 3,825 | 3,785 | 3,785 | +5 | +0.1% | 92,500 |
2017/12/26 | 3,810 | 3,825 | 3,780 | 3,780 | -20 | -0.5% | 109,600 |
2017/12/25 | 3,790 | 3,815 | 3,780 | 3,800 | +25 | +0.7% | 82,500 |
2017/12/22 | 3,735 | 3,800 | 3,735 | 3,775 | +40 | +1.1% | 240,700 |
2017/12/21 | 3,755 | 3,775 | 3,735 | 3,735 | -65 | -1.7% | 382,500 |
2017/12/20 | 3,730 | 3,800 | 3,730 | 3,800 | +75 | +2% | 214,200 |
2017/12/19 | 3,795 | 3,795 | 3,720 | 3,725 | -65 | -1.7% | 221,900 |
2017/12/18 | 3,735 | 3,795 | 3,735 | 3,790 | +80 | +2.2% | 233,800 |
2017/12/15 | 3,740 | 3,740 | 3,705 | 3,710 | -45 | -1.2% | 183,500 |
2017/12/14 | 3,740 | 3,765 | 3,720 | 3,755 | +30 | +0.8% | 183,500 |
2017/12/13 | 3,735 | 3,760 | 3,720 | 3,725 | +20 | +0.5% | 185,700 |
2017/12/12 | 3,725 | 3,725 | 3,690 | 3,705 | -5 | -0.1% | 232,500 |
2017/12/11 | 3,750 | 3,750 | 3,675 | 3,710 | -10 | -0.3% | 212,400 |
2017/12/08 | 3,650 | 3,720 | 3,650 | 3,720 | +50 | +1.4% | 353,400 |
2017/12/07 | 3,655 | 3,680 | 3,625 | 3,670 | +40 | +1.1% | 252,700 |
2017/12/06 | 3,740 | 3,740 | 3,625 | 3,630 | -120 | -3.2% | 430,800 |
2017/12/05 | 3,750 | 3,760 | 3,700 | 3,750 | -30 | -0.8% | 222,100 |
2017/12/04 | 3,820 | 3,830 | 3,780 | 3,780 | -40 | -1% | 228,000 |
2017/12/01 | 3,900 | 3,900 | 3,810 | 3,820 | -60 | -1.5% | 238,700 |
2017/11/30 | 3,805 | 3,880 | 3,800 | 3,880 | +75 | +2% | 393,300 |
2017/11/29 | 3,815 | 3,815 | 3,790 | 3,805 | ±0 | ±0% | 192,600 |
2017/11/28 | 3,820 | 3,835 | 3,795 | 3,805 | -30 | -0.8% | 286,400 |
2017/11/27 | 3,880 | 3,890 | 3,825 | 3,835 | -35 | -0.9% | 250,100 |
2017/11/24 | 3,865 | 3,880 | 3,850 | 3,870 | -10 | -0.3% | 210,400 |
2017/11/22 | 3,915 | 3,935 | 3,875 | 3,880 | +5 | +0.1% | 366,300 |
2017/11/21 | 3,900 | 3,910 | 3,860 | 3,875 | -45 | -1.1% | 332,400 |
2017/11/20 | 3,940 | 3,940 | 3,905 | 3,920 | -25 | -0.6% | 333,700 |
2017/11/17 | 3,930 | 3,970 | 3,870 | 3,945 | -195 | -4.7% | 1,133,700 |
2017/11/16 | 4,090 | 4,160 | 4,070 | 4,140 | +15 | +0.4% | 251,300 |
2017/11/15 | 4,215 | 4,245 | 4,125 | 4,125 | -130 | -3.1% | 264,600 |
2017/11/14 | 4,320 | 4,370 | 4,245 | 4,255 | -60 | -1.4% | 195,100 |
2017/11/13 | 4,330 | 4,350 | 4,315 | 4,315 | -60 | -1.4% | 195,400 |
2017/11/10 | 4,425 | 4,430 | 4,335 | 4,375 | -100 | -2.2% | 456,000 |
2017/11/09 | 4,480 | 4,615 | 4,450 | 4,475 | +275 | +6.5% | 841,900 |
2017/11/08 | 4,250 | 4,250 | 4,185 | 4,200 | -35 | -0.8% | 232,100 |
2017/11/07 | 4,215 | 4,245 | 4,190 | 4,235 | -5 | -0.1% | 160,900 |
1801~
1850
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム